Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or California for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to California only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. California (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

University Of California Irvine (NPI 1689608150)

Field	Value
Entity Type	Organization
Organization	University Of California Irvine
Address	101 The City Dr S
City	Orange
State	CA
ZIP	92868
Taxonomy	General Acute Care Hospital
NPI Enumerated	July 10, 2006

Payer Source	Total Paid
Medicaid	$153.1M
Medicare	$0

Key Findings

This provider reports no Medicare billing on file and $153.1M in lifetime Medicaid revenue, making its public claims footprint effectively single-payer (Medicaid) in the available data. The absence of Medicare revenue means analyses of Medicare mix or comparative national Medicare positioning are not possible from these records.

Revenue is highly concentrated: the precomputed top three Medicaid codes account for 37.7% of total Medicaid revenue, driven primarily by J9271 (pembrolizumab) at $20.4M (22.3%), followed by J9299 (nivolumab) at $7.2M (7.9%) and J1561 (immune globulin) at $6.8M (7.4%). This concentration indicates a large share of Medicaid dollars are tied to high-cost biologic and infusion therapies.

The code mix and high-paid oncology drug line items point to a dominant oncology and infusion service-line: J9271 (9.6K claims, $2117 avg paid/claim), J9299 (4K claims, $1823 avg paid/claim), J9035 (bevacizumab), J1745 (infliximab), and chemotherapy administration codes such as 96413 and 96374 appear among top revenue drivers. Coupled with modality codes like 77386 (IMRT) and 78815 (PET/CT), the pattern is consistent with an integrated cancer center delivering systemic therapy, image-guided radiation, and advanced diagnostic imaging.

Competitive standing within the state is strong for multiple high-cost drugs and services: the provider ranks #1 of 57 for J9271 (100th percentile; extreme outlier) and #1 of 9 for J1561 (100th percentile; notably above typical state volume), and ranks #2 of 20 for J9299 (95th percentile; notably above typical state volume). These rankings indicate the facility is a leading statewide provider for several oncology and infusion therapies rather than a modest participant.

Outpatient clinic, imaging, and procedural throughput are also substantial: G0463 shows 162.3K claims and $6.7M in revenue (rank #3 of 267, 99th percentile; extreme outlier), 74177 has 20.8K claims and $3.8M revenue (97th percentile; notably above typical state volume), and 78815 contributes $4.4M (94th percentile; notably above typical state volume). High clinic visit and imaging volumes support the inference of a high-capacity outpatient and ambulatory oncology operation.

Emergency and ancillary volumes further reflect wide service breadth: 99285 (ED high-complexity visits) appears with 8.3K claims and $2.9M revenue, ambulance A0429 shows 53.8K claims and $2.2M revenue (rank #12 of 386, 97th percentile; notably above typical state volume), and molecular testing codes 87636/87637 are present at notable volumes. These items indicate the provider operates comprehensive acute-care and support services alongside specialty care.

Several codes are flagged as statistical outliers in-state, reinforcing the provider's role as a high-volume referral center: J9271, J1561, J0897, J9306 and 96413 are all at or near the 100th percentile and described as extreme outliers or notably above typical state volume. That pattern highlights concentrated expertise and capacity for expensive biologic and chemotherapy services relative to peers.

The provider’s NPI was enumerated on 2006-07-10 (~20 years ago), indicating an established presence in the market; combined with the Medicaid revenue scale and the state-level high-percentile rankings across oncology drugs, imaging, and infusion codes, the dataset is consistent with a long-standing regional referral hospital with a heavy clinical focus on cancer care and complex outpatient services.

Medicaid: Complete Services Breakdown

Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.

879 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	9,620	$2,120	$20.4M
J9299	Injection, nivolumab, 1 mg	3,970	$1,820	$7.2M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	9,070	$750	$6.8M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	162,270	$40	$6.7M
J9035	Injection, bevacizumab, 10 mg	4,510	$1,190	$5.4M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2,250	$2,040	$4.6M
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	3,350	$1,310	$4.4M
74177	The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs.	20,790	$190	$3.8M
99285	The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making.	8,320	$350	$2.9M
77386	Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex	13,710	$200	$2.8M

Showing 1–10 of 879

Medicaid: Competitive Analysis & Benchmarks

How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.

Claims Volume vs. California Distribution

University Of California Irvine — 14 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — California

Full comparison — all codes billed, vs. California median

879 rows

CPT/HCPCS Code	Description	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
0450	N/A	61	450	16,140	$90	$3.6M
J9271	Injection, pembrolizumab, 1 mg	1	60	240	$4,460	$3.4M
J9299	Injection, nivolumab, 1 mg	2	20	810	$3,160	$3.1M
J9264	Injection, paclitaxel protein-bound particles, 1 mg	4	10	60	$2,520	$2.9M
0121	N/A	43	70	130	$4,600	$2.6M
77386	Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex	2	20	880	$600	$2.4M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	1	10	1,000	$790	$1.8M
A0429	Ambulance service, basic life support, emergency transport (bls-emergency)	12	390	1,270	$220	$1.5M
J2505	Injection, pegfilgrastim, 6 mg	4	30	220	$2,310	$1.2M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	8	20	260	$2,370	$1.2M

Showing 1–10 of 879

Related Providers

Other providers that share a Tax Identification Number (TIN) with University Of California Irvine, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of California Irvine	CA	Federally Qualified Health Center (FQHC)	$0	$40M
University Of California Irvine	CA	Federally Qualified Health Center (FQHC)	$0	$27M
Amar Amin	CA	Diagnostic Radiology Physician	$3.6M	$6.5K
Brian Kim	CA	Ophthalmology Physician	$2.6M	$8.9K
Robby Ayoub	CA	Pulmonary Disease Physician	$281.4K	$1.7M
Vivian Laquer	CA	Dermatology Physician	$94.8K	$1.7M
Quoc Nguyen	CA	Otolaryngic Allergy Physician	$293.1K	$1.2M
Steven Davis	CA	Radiation Oncology Physician	$1.4M	$0
Ryan Klein	CA	Internal Medicine Physician	$1.3M	$0
Lalita Pandit	CA	Hematology & Oncology Physician	$542.4K	$720.8K

Nearby Providers

Other providers in the same ZIP code as University Of California Irvine, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Falck Mobile Health Corp	CA	Land Ambulance	$25.5M	$127.7M
St. Joseph Hospital Of Orange	CA	General Acute Care Hospital	$0	$65.9M
Children's Hospital Of Orange County	CA	Children's Hospital	$0	$53.7M
Emergency Medicine Specialists Of Orange County	CA	Emergency Medicine Physician	$0	$42.4M
Maxim Healthcare Services, Inc.	CA	Home Health Agency	$0	$37.3M
Premier Healthcare Services, LLC	CA	Home Health Agency	$0	$35M
Vital Smiles Alabama Ii PC	CA	Dentist	$0	$29.2M
Gordian Medical, Inc.	CA	Durable Medical Equipment & Medical Supplies	$0	$27.5M
Bio-medical Applications Of California, Inc.	CA	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$24.6M
Acuity Behavior Solutions LLC	CA	Behavior Analyst	$0	$23.2M

University Of California Irvine — Billing Profile & Reimbursement Data

Sign up for University Of California Irvine — Billing Profile & Reimbursement Data policy alerts

University Of California Irvine — Billing Profile & Reimbursement Data

Sign up for University Of California Irvine — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicaid: Total Revenue Breakdown by CPT/HCPCS Code

Medicaid: Complete Services Breakdown

Medicaid: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References